Kate Aubusson of the Sydney Morning Herald reports that Australia’s Garvan Institute of Medical Research is attempting to unleash the power of immunotherapy to treat triple negative breast cancers. According to the article, almost one in four women with triple negative breast cancer will die within five years of being diagnosed—this compares to 7% of women with other breast cancer types. Dr. Valdes Mora has secured one of 21 fellowships and a share in $10.4 million from the NSW government and the Cancer Institute NSW to find a way of killing off triple negative breast cancers with epigenetic drugs and immunotherapy.
Follow the link to Ms. Aubusson’s story for more details.
Lead Research/InvestigatorSource: Sydney Morning Herald